This site uses cookies to store information on your computer. I'm fine with this Cookie information
Follow is on Twitter Like us on Facebook Follow us on Instagram
Covid-19 (Coronavirus)

Information and guidance for public, NHSGGC staff, and community-based services.  Hospital visiting restrictions now in place.

Insulin C - peptide

Insulin C-peptide (connecting peptide), a 31 amino acid polypeptide, represents the midportion of proinsulin. During insulin secretion it is enzymatically cleaved from proinsulin and co-secreted in equimolar proportion with mature insulin. The half life of C-peptide is significantly longer than insulin, so it is detectable in higher concentrations and the level less variable. C-peptide is often a more reliable marker than insulin. In addition, insulin is destroyed by proteases in haemolysed samples, while C-peptide is not.

Clinical uses:

1. Insulinoma: elevated C-peptide levels from increased beta-cell activity

2. Covert self-administration of insulin: can be virtually ruled out as cause of hyperinsulinaemia by finding elevated C-peptide.

3. Type 1 diabetes mellitus: low C-peptide levels due to diminished insulin secretion, or suppressed as a normal response to exogenous insulin. Patients on insulin can develop anti-insulin antibodies which can interfere with insulin assay, so C-peptide can be used instead to check residual beta-cell activity.

Sample Requirements and Reference Ranges

Sample type  Plasma
Container  Lithium heparin
Precautions  Collect after overnight fast. Separate and freeze plasma.  Transport frozen.
Minimum volume  1 mL
Reference range Not applicable
Turnaround time  7 days
Method  Siemens Immulite
 
Quality Assurance
UK NEQAS
Last Updated: 13 October 2020